Murine succinate semialdehyde dehydrogenase deficiency.

Area of Science:

• Neurogenetics
• GABA metabolism disorders
• Animal models of human disease

Background:

• Inherited succinic semialdehyde dehydrogenase (SSADH) deficiency, also known as gamma-hydroxybutyric aciduria, is a rare neurogenetic disorder affecting GABA metabolism.
• This condition is characterized by tonic-clonic seizures and elevated levels of GABA and gamma-hydroxybutyrate (GHB) in the central nervous system.

Purpose of the Study:

• To develop and characterize a murine knockout model of SSADH deficiency for studying disease pathomechanisms.
• To explore potential preclinical treatment strategies for SSADH deficiency.
• To investigate the impact of GABA and GHB accumulation on central nervous system development and function.

Main Methods:

• Development of a SSADH knockout mouse model (SSADH-/-).
• Electrophysiological analyses of mutant mice.
• Assessment of GABA/glutamine axis disruption, dopamine metabolism, neurosteroid levels, and oxidative stress in SSADH-/- mice.

Main Results:

• SSADH-/- mice exhibit 100% mortality by 3-4 weeks of life due to generalized tonic-clonic seizures.
• Evidence of disrupted GABA/glutamine axis, oxidative stress, altered dopamine metabolism, and abnormal neurosteroid levels in SSADH-/- mouse brains.
• Preliminary data on effective pharmacotherapeutic and gene-therapy approaches were summarized.

Conclusions:

• The SSADH-/- mouse is a valuable model for understanding the neurobiological consequences of GABA and GHB accumulation.
• Findings suggest potential involvement of the GABA(A) receptor in the pathogenesis of SSADH deficiency.
• This model can facilitate the exploration of novel therapeutic interventions for this rare neurological disorder.